|
|
|
| The 4th Nasal Formulation & Delivery Summit is uniting formulation, delivery, and product development leaders to advance the development of safe, effective, and commercially viable intranasal therapies. Join 70+ experts from Eli Lilly, Bayer, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, and more to explore real-world preclinical and clinical data, compare liquid and powder nasal approaches, and align on best practices for systemic and nose-to-brain delivery. |
|
|
|
|
By Narinder Bhalla, MD and José Manuel Otero, Ph.D., Lexeo Therapeutics | As the field matures, the most transformative gene therapies in heart health are treating delivery not as an afterthought but as a fundamental principle. | |
|
|
Therapeutic Targets For Oral Peptide Delivery | By Drug Delivery Leader: Sit and Deliver | Videocast host Tom von Gunden invites Dinesh Patel, president and CEO at biotech company Protagonist Therapeutics, to deliver the rationale for targeting I&I diseases and other therapeutic areas with oral peptides. |
|
|
|
| De-Risking FDA ANDA Submission For Disposable Pen | Infographic | BD Medical - Pharmaceutical Systems | This disposable pen for Semaglutide is a generic drug-device combination, designed for usability and regulatory compliance, showing comparable performance to the reference device. |
|
|
| Optimizing Syringe Performance For Reliable Drug Delivery | Article | West Pharmaceutical Services, Inc. | Reliable drug delivery requires precision. Maintaining a robust seal throughout a product’s shelf life is essential to preserve sterility and ensure patient safety during self-administration. |
|
|
|
|
|
|
|
.png){kind=logo}
